Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

1700061G19Rik Inhibitors

1700061G19Rik Inhibitors encompass a diverse range of compounds characterized by their ability to modulate the biological activity of the protein encoded by the gene 1700061G19Rik. This protein, due to its involvement in various cellular signaling pathways, presents a target for compounds that can influence these pathways either directly or indirectly. The inhibitors identified for this class do not act on the protein 1700061G19Rik directly; instead, they exert their effects by modulating the pathways and processes in which this protein is implicated. The range of compounds in this class is broad, reflecting the complexity and multifaceted nature of the cellular functions associated with 1700061G19Rik.

Among the compounds classified as 1700061G19Rik Inhibitors, there is a notable diversity in their modes of action, reflecting the various signaling pathways with which 1700061G19Rik is associated. For instance, Metformin and Rapamycin, while chemically distinct, both play roles in metabolic and growth regulation pathways, respectively, which can intersect with the functions of 1700061G19Rik. Similarly, compounds like Staurosporine and LY294002 target protein kinases and PI3K pathways, which are crucial in a range of cellular processes, including those in which 1700061G19Rik may be involved. This variability in mechanism underscores the complexity of targeting a protein involved in multiple pathways. Other compounds, such as Wnt Inhibitor (IWP-2) and Cyclopamine, demonstrate the focus on signaling pathways, like Wnt and Hedgehog, indicating a strategy of modulating upstream or downstream processes that feed into the roles played by 1700061G19Rik. This approach is mirrored in inhibitors like NF-κB Inhibitor (JSH-23) and SP600125, which target NF-κB and JNK pathways, respectively, highlighting the potential intersections with inflammatory and stress response pathways. The inclusion of compounds like Z-VAD-FMK, a pan-caspase inhibitor, further illustrates the broad spectrum of cellular processes potentially influenced by 1700061G19Rik, including those related to cell death and survival.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

As an mTOR inhibitor, rapamycin impacts cellular growth and proliferation pathways, which has shown to intersect with any growth-regulatory roles of 1700061G19Rik.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent inhibitor of protein kinases, staurosporine can influence a wide range of cellular signaling pathways, which has shown to affect the activity of 1700061G19Rik.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$94.00
$286.00
27
(1)

IWP-2 inhibits Wnt processing and secretion, which has shown to impact pathways associated with 1700061G19Rik if it's involved in Wnt signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

As a PI3K inhibitor, LY294002 affects multiple signaling pathways, including those related to cell survival and proliferation, which may intersect with 1700061G19Rik's functions.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

This compound inhibits MEK, part of the MAPK/ERK pathway, which has shown to affect cellular processes regulated by 1700061G19Rik.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

As a p38 MAPK inhibitor, it could affect inflammatory response and stress response pathways, which has shown to intersect with 1700061G19Rik's activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, SP600125 impacts stress response and apoptotic pathways, which has shown to be relevant to the functions of 1700061G19Rik.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

This compound inhibits the Hedgehog signaling pathway, which may intersect with roles played by 1700061G19Rik.

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$74.00
256
(6)

A pan-caspase inhibitor, Z-VAD-FMK can affect apoptotic pathways, which has shown to be relevant if 1700061G19Rik is involved in cell death regulation.